- My Alerts
- Go Ad-Free
-
My Account
In App
BSE Live
Feb 20, 11:05Prev. Close
6293.60
Open Price
6286.10
Bid Price (Qty.)
6265.95 (17)
Offer Price (Qty.)
6272.30 (3)
NSE Live
Feb 20, 11:05Prev. Close
6297.50
Open Price
6297.50
Bid Price (Qty.)
6267.00 (47)
Offer Price (Qty.)
6270.00 (31)
| Cash Flow of Divis Laboratories (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 2,929.00 | 2,132.00 | 2,354.10 | 3,676.52 | 2,627.87 | |
| Net CashFlow From Operating Activities | 1,650.00 | 1,266.00 | 2,447.95 | 1,910.16 | 1,947.05 | |
| Net Cash Used In Investing Activities | -803.00 | -268.00 | -2,706.75 | -2,195.40 | 75.34 | |
| Net Cash Used From Financing Activities | -797.00 | -798.00 | -796.59 | -531.50 | -33.97 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 50.00 | 200.00 | -1,055.39 | -816.74 | 1,988.42 | |
| Cash And Cash Equivalents Begin of Year | 344.00 | 144.00 | 1,199.56 | 2,016.30 | 27.88 | |
| Cash And Cash Equivalents End Of Year | 394.00 | 344.00 | 144.17 | 1,199.56 | 2,016.30 |
12.02.2026
Accumulate Divis Laboratories; target of Rs 6850: Prabhudas Lilladher
20.11.2025
Accumulate Divis Laboratories; target of Rs 6795: Deven Choksey
14.11.2025
Divis Labs Consolidated September 2025 Net Sales at Rs 2,715.00 crore, up 16.12% Y-o-Y
12.11.2025
Neutral Divis Laboratories; target of Rs 6925: Motilal Oswal
24.05.2024
Divi's Labs Q4 preview: Revenue, net profit to grow on normalised base, better product mix
04.11.2023
Divi's Labs Q2 Preview: Earnings likely to improve sequentially on better margins, product mix
14.08.2023
Divi's Labs Q1 Preview: Base effect to pressure earnings, brokerages predict sequential recovery
19.05.2023
Divi's Labs Preview: Unfavourable base, elevated input costs to turn Q4 a sour pill
